Literature DB >> 20961192

Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.

Stephen Holding1, Dorothy Spradbery, Robin Hoole, Rachel Wilmot, Michael L Shields, Alison M Levoguer, Philip C Doré.   

Abstract

BACKGROUND: Serum free light chain (FLC) analysis is used in the prognostic assessment and monitoring of patients with monoclonal gammopathies (MG). Its use in detection of MG is less widespread despite good sensitivity for diseases poorly detected by serum protein electrophoresis (SPE), e.g., FLC disease and AL amyloidosis. FLC analysis may facilitate earlier diagnosis in these diseases. However, if replacing urine protein electrophoresis (UPE) in an initial screening algorithm, this must be balanced against any loss of detection of Bence Jones proteinuria (BJP).
METHODS: We assessed the effect of replacing UPE with FLC. Sensitivity of FLC for BJP was assessed in 126 clinical cases where UPE and FLC analyses were performed. Impact on disease detection was assessed from 753 patient sera tested by SPE and FLC and 128 patients matched associated urine samples.
RESULTS: Sensitivity of FLC for BJP was 98%. Use of FLC in routine testing increased the number of MG detected by 7%.
CONCLUSIONS: Using FLC alongside or in place of UPE can give clinical benefit through earlier diagnosis and hence treatment earlier in the patients' disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961192     DOI: 10.1515/CCLM.2011.010

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

Review 1.  The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.

Authors:  Punit Yadav; Nelson Leung; Paul W Sanders; Paul Cockwell
Journal:  Kidney Int       Date:  2014-10-08       Impact factor: 10.612

2.  Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Authors:  Thomas Dejoie; Jill Corre; Helene Caillon; Cyrille Hulin; Aurore Perrot; Denis Caillot; Eileen Boyle; Marie-Lorraine Chretien; Jean Fontan; Karim Belhadj; Sabine Brechignac; Olivier Decaux; Laurent Voillat; Philippe Rodon; Olivier Fitoussi; Carla Araujo; Lotfi Benboubker; Charlotte Fontan; Mourad Tiab; Pascal Godmer; Odile Luycx; Olivier Allangba; Jean-Michel Pignon; Jean-Gabriel Fuzibet; Laurence Legros; Anne Marie Stoppa; Mamoun Dib; Brigitte Pegourie; Frederique Orsini-Piocelle; Lionel Karlin; Bertrand Arnulf; Murielle Roussel; Laurent Garderet; Mohamad Mohty; Nathalie Meuleman; Chantal Doyen; Pascal Lenain; Margaret Macro; Xavier Leleu; Thierry Facon; Philippe Moreau; Michel Attal; Herve Avet-Loiseau
Journal:  Blood       Date:  2016-10-11       Impact factor: 22.113

3.  A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.

Authors:  Eldho Kuriakose; Sumithra Narayanan Unni Cheppayil; Subhakumari Kuzhikandathil Narayanan; Anu Vasudevan
Journal:  Indian J Clin Biochem       Date:  2017-11-29

4.  Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.

Authors:  Thomas Dejoie; Michel Attal; Philippe Moreau; Jean-Luc Harousseau; Herve Avet-Loiseau
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

5.  Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.

Authors:  Gurmukh Singh
Journal:  J Clin Med Res       Date:  2016-11-24

6.  A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice.

Authors:  Birgitte Sandfeld-Paulsen; Ninna Aggerholm-Pedersen; Mie Hessellund Samson; Holger Jon Møller
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

7.  Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Authors:  Brian D Nicholson; Jason L Oke; Peter W Rose; David Mant
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.